Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,424
Closed -$766K 91
2026
Q1
$766K Hold
6,424
0.06% 63
2025
Q4
$875K Buy
6,424
+756
+13% +$109K 0.07% 65
2025
Q3
$835K Sell
5,668
-819
-13% -$114K 0.09% 55
2025
Q2
$838K Buy
6,487
+3,230
+99% +$391K 0.13% 36
2025
Q1
$360K Sell
3,257
-7,493
-70% -$929K 0.07% 38
2024
Q4
$1.2M Buy
+10,750
New +$1.36M 0.3% 30
2024
Q3
Sell
-7,964
Closed -$1.01M 51
2024
Q2
$1.01M Buy
7,964
+641
+9% +$87.2K 0.32% 33
2024
Q1
$877K Hold
7,323
0.39% 30
2023
Q4
$759K Buy
7,323
+1,233
+20% +$123K 0.4% 18
2023
Q3
$555K Buy
6,090
+1,848
+44% +$191K 0.28% 30
2023
Q2
$476K Buy
+4,242
New +$449K 0.23% 33

Other funds holding XYL

Algebris (UK)'s XYL Position: Q2 2026 in Review

Algebris (UK) sold out of Xylem (XYL) in Q2 2026, closing a stake of 6,424 shares — an estimated $766K sold.

Algebris (UK) first reported a position in XYL in Q2 2023 and held it in 11 quarters. The position peaked at $1.2M in Q4 2024. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Algebris (UK) reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Algebris (UK) sold 6,424 Xylem shares in Q2 2026, an estimated $766K.
  • Algebris (UK) first reported a position in Xylem in Q2 2023 and held it in 11 quarters.
  • Algebris (UK)'s Xylem position peaked at $1.2M in Q4 2024.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Algebris (UK)'s 13F filing for Q2 2026, filed 11 Aug 2026.